Biovanta
Tirzepatide 40mg, photo 1 of 3
1 / 3
Metabolic peptideAvailable now

Tirzepatide

40 mg · pre-filled · sealed

Two receptors, one pen. Tirzepatide is the most-studied dual agonist in the incretin class — GIP and GLP-1 working the appetite and blood-sugar pathways side by side.

£160

£4.00/mg

  • Order by 11pm, dispatched next working day, tracked
  • Plain, unbranded box, sealed and padded

Lab certificate

Janoshik · analysed 27 Aug 2026

Purity 99.59%

17.72 mg/ml

  • Swiss-made
  • Every batch tested
  • Sealed pre-filled pen
  • Tracked UK delivery

What it is

A dual GLP-1 / GIP receptor peptide, the most-cited compound in the class.

Two receptors fire at once — GIP and GLP-1 — so appetite and blood-sugar response are studied in tandem rather than one after the other. One pen covers the full titration schedule.

Supports

  • Appetite regulation
  • Balanced blood sugar

The satiety pathway. Studied for how the GLP-1 pathway signals fullness and quietens appetite.

The insulin pathway. The GIP arm is researched for how cells take up insulin and handle glucose.

The markers that matter. Investigated across body-weight and blood-sugar research together.

What arrives

  • 1 pre-filled pen — 4 × 10 mg doses
  • 12 disposable 5 mm needles
  • Pre-injection swabs, 70% isopropanol
  • Lab certificate for the batch
  • Next-day UK dispatch, tracked

Refrigerate 2–8°C. Protect from light in the original carton. Do not freeze, and do not store the pen with a needle attached. Discard the device 12 weeks after first use.

The pen

One sealed pen. Nothing to mix.

Filled and sealed in Switzerland, so what arrives is the finished article: no powder, no water, no measuring by hand.

Tirzepatide 40mg pre-filled pen

01

The cap

Clips on over the needle end. Nothing to assemble.

02

The window

Shows what is left in the sealed cartridge.

03

The dial

Turns in fixed clicks; the reading is printed on the barrel.

04

The knob

Knurled, with the bronze ring. One click, one stop.

Before you order

What is Tirzepatide?

Tirzepatide is a synthetic dual-receptor peptide (GIP and GLP-1), supplied as a pre-filled research pen for controlled analytical and in-vitro experimentation. It is intended strictly for in-vitro laboratory research use only.

What is it studied for in research?

In preclinical and cell-based research it is examined for dual incretin-pathway signalling — GLP-1 for appetite/satiety signalling and GIP for insulin response and glucose handling. These are laboratory research observations only and are not established human or veterinary effects.

How does it compare to Retatrutide?

Tirzepatide is a dual agonist (GIP + GLP-1); Retatrutide adds a third receptor (glucagon). Both are supplied as identical pre-filled pens — the choice is a research one.

Is it legal to buy in the UK?

Tirzepatide is legal to buy and possess in the UK for laboratory research purposes. It is not a licensed medicine and cannot be sold for human or veterinary consumption — every pen is labelled for in-vitro research use only, and the purchaser is responsible for handling and storage under applicable regulations.

What purity is it, and is it lab-tested?

This batch was tested independently by Janoshik: batch Ti40-20260508, 99.59% purity, 17.72 mg/ml. Verify it yourself at janoshik.com with key 3LVUVSTF2SW8. Manufactured in Switzerland, held and dispatched from the UK.

Do you send the test results?

Yes — the Janoshik report is summarised above with its verify key, and the full report is available on live chat or by email at [email protected], before you order if you like.

How is it supplied?

A pre-filled multi-dose research pen (40 mg total), with single-use needles. Ready out of the box, no reconstitution.

Also in the range

Research use only. Not for human or veterinary consumption. The purchaser is responsible for compliant handling and storage.

Tirzepatide · 40 mg

£160